Trials
1 active
1 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Klenzit®-C (Adapalene/Clindamycin Phosphate Gel) Description: Topical gel containing adapalene 1 mg/g and clindamycin 10 mg/g, applied once daily to acne-affected areas of the face after cleansing and drying the skin. It is prescribed as part of routine clinical practice and not assigned by the study.”In the company’s words, NCT07918001 on ClinicalTrials.gov
- Tested for
- Acne
- Main trialPhase 4
- “The CLEAN ACNE Study is a prospective, observational, Phase IV, open-label, multicenter, single-arm study at 3-5 sites in Vietnam. It will describe the safety, tolerability, and clinical effectiveness of adapalene 0.1%/clindamycin 1% fixed-dose combination gel (Klenzit®-C) as used in routine clinical practice. Participants are Vietnamese patients aged 12 years and older with mild to moderate acne vulgaris. Patients whose treating physician has already prescribed Klenzit®-C as part of routine care will be invited to take part. The decision to prescribe is made independently of the study.…”In the company’s words, NCT07918001 on ClinicalTrials.gov
Other drugs for Acne
- TrifaroteneGalderma R&D · Phase 3
- Cyproterone Acetate and Ethinyl EstradiolEurofarma Laboratorios S.A. · Phase 3
- DenifanstatSagimet Biosciences Inc. · Ascletis · Phase 3
- ClascoteroneZhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. · Phase 3
- B244AOBiome LLC · Phase 2
- Acne mRNA vaccineSanofi · Phase 1/2
Coming up1
- 28 Feb 2027Phase 4 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 4Recruiting | 28 Feb 2027 | Safety, Tolerability, and Clinical Effectiveness of Adapalene/Clindamycin Phosphate Gel (Klenzit®-C) in Vietnamese Patients With Mild to Moderate Acne Vulgaris |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026